Radiographic Findings and Clinical Outcomes After Bone Grafting Patellar Defect in ACL Reconstruction

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
University of Arizona
Study ID
NCT06975306
Status
Recruiting

Conditions

  • ACL Injuries
  • Bone Graft; Complications

Eligibility Criteria

Sex
ALL
Age
18 Years - 40 Years
Healthy Volunteers
Not accepted

Interventions

  • autologous bone grafts — PROCEDURE
    group will be treated with autologous bone graft for BTB ACLR
  • Demineralized bone matrix (DBM) — OTHER
    Demineralized bone matrix (DBM) is a biologic allograft product derived from bone tissue that has undergone a process of demineralization to remove inorganic mineral components while retaining the organic matrix, including proteins and growth factors.

Study Details

All patients will be randomly assigned using a computer randomization algorithm to one of two matched cohort groups. Patients will not be advised which group they belong to until after the completion of the study. One group will be treated with autologous bone graft for bone patellar-tendon bone (BTB) Anterior Cruciate Ligament Reconstruction (ACLR), and the other group will be treated with commercially available DBM (Demineralized bone matrix) putty. Patients will be enrolled from Banner University. Before and after surgery, patient reported outcomes including visual analog pain scale (VAS), Tegner-Lysholm and Cincinnati ACL Test. The principal investigator will evaluate the patients on subjective criteria such as pain and objective criteria including range of motion, arthritic changes seen on radiographs, infection, and ability to kneel.

Key Dates

Start date
Feb 11, 2025
Status verified
May 2025
Primary completion
May 31, 2026
Completion
May 31, 2026

Study Design

Enrollment
75 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: autologous bone graft
    One group will be treated with autologous bone graft for BTB ACLR
  • Experimental: Demineralized bone matrix (DBM) putty
    Demineralized bone matrix (DBM) is a biologic allograft product derived from bone tissue that has undergone a process of demineralization to remove inorganic mineral components while retaining the organic matrix, including proteins and growth factors.

Primary Outcome Measure

change in surgical time [ Time Frame: Duration of Procedure ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Banner Health Center Plus - ArcadiaPhoenixArizona85008
Marleny Munoz
602-793-9582
Banner University Medical Center PhoenixPhoenixArizona85006
Marleny Munoz
602-793-9582
Banner Sports Medicine ScottsdaleScottsdaleArizona85256
Marleny Munoz
602-793-9582

Find similar trials in Phoenix, AZ

Related Studies